Research and Markets - Global Hematopoietic Stem Cell Transplantation Market to Reach $10 Billion by 2025 - Key Players are Kite Pharma, Lonza Group & Novartis AG

The Global Hematopoietic Stem Cell Transplantation Market is poised to grow at a CAGR of around 11.4% over the next decade to reach approximately $10.9 billion by 2025. Some of the prominent trends that the market is witnessing include technological advancements in regenerative stromal cell therapy, development of transplantation activity across the globe, recent technological developments of Hematopoietic Stem Cell Transplantation and growth opportunities/investment opportunities.

Based on application the market is categorized into solid tumors, leukemia, non-malignant disorders and lymphoproliferative disorders. Depending on the transplant type the market is segmented by allogeneic transplant and autologous transplant.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Report Highlights:

Companies Mentioned:

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Hematopoietic Stem Cell Transplantation Market, By Application

5 Hematopoietic Stem Cell Transplantation Market, By Transplant Type

6 Hematopoietic Stem Cell Transplantation Market, By Geography

7 Key Player Activities

8 Leading Companies

For more information about this report visit http://www.researchandmarkets.com/research/m68rrm/global

Media Contact:

Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716